Procaps Group S.A. (PROC) Short-Term Debt to Capital

Procaps Group S.A. - graphic logo of issuer PROC

The price chart for Procaps Group S.A. (PROC) reflects a trend where the indicator currently stands at 0.00. The business relies on exclusive capsule patents and influential connections in Latin America under strict FDA oversight. Procaps Group S.A. (PROC) attracts the region's leading technologists by offering them accelerated career growth. Production capacities are fully utilized, while equipment for monitoring product geometry is being actively upgraded.

Procaps Group SA (PROC) Ratio of Short-Term Indebtedness to Capital: for the period 07/04/2022 - 02/16/2025

Metric breakdowns and analytics for procapsgroup.com (PROC)

- price and consensus price forecast:
Stock Price Procaps Group SA|PROC - Fair Value Consensus
- market capitalization data:
Market Capitalization Procaps Group S.A.|PROC - Enterprise Value
- book capitalization data:
Net Assets per Single Share Procaps|PROC - Accounting Value of Company|Market Value to Book Value Ratio procapsgroup.com|PROC - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Procaps Group S.A.|PROC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Procaps|PROC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Procaps Group S.A.
General company analysis:Procaps Group SA (PROC)
Brand item of Procaps Group

To find fundamental support in Procaps Group S.A. (PROC), it is essential to evaluate the balance between expansion and stability, where the short-term debt-to-equity ratio measures the proportion of liabilities maturing within one year relative to equity, reflecting the global capsule manufacturer's reliance on current borrowing, which, given the brand's strong B2B reputation, allows for the management of interest rate risks during business scaling.

Competitors of Procaps Group S.A.

Haleon Group (HLN) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Kenvue Health (KVUE)|Short-Term Debt to Capital VRNA (Verona Pharma plc)|jyongbio.com - Short-Term Debt to Capital|Short-Term Debt to Equity Ligand (LGND)|AMRX: Ratio of Short-Term Indebtedness to Capital|PRGO (Perrigo Company) - Short-Term Debt to Equity|Alvotech Biopharmaceuticals (ALVO) - Short-Term Debt to Equity Ratio|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com (GLPG)|ANI Pharmaceuticals, Inc. (ANIP) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital MNKD (MannKind Corp)|AMPH: Short-Term Debt to Equity|PCRX - Current Liabilities to Capital|Short-Term Debt to Equity Ratio ARS Pharmaceuticals SPRY|TBPH - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital Aquestive Therapeutics, Inc. AQST|scPharmaceuticals (SCPH) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TECX (Tectonic Therapeutic Inc.)|Current Liabilities to Capital TNXP|China SXT Pharmaceuticals (SXTC) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital EPRX (eupraxiapharma.com)|BioHarvest Sciences Inc. (BHST) - Short-Term Debt to Equity|Invizyne Technologies - Current Liabilities to Equity|Short-Term Debt to Equity Oramed Pharma (ORMP)|ENTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity HYFT|abvcpharma.com (ABVC) - Current Liabilities to Capital|Short-Term Debt to Capital CPIX|Short-Term Debt to Equity Ratio Quantum BioPharma Ltd.|Short-Term Debt to Capital FGEN|Short-Term Debt to Capital TELO (Telomir Pharmaceuticals Corp)|Rani Therapeutics Holdings, Inc. (RANI) - Short-Term Debt to Equity|Synergy CHC Corp. - Current Liabilities to Equity|Short-Term Debt to Equity RLYB (Rallybio Corp.)|Lexaria Bioscience (LEXX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Pulmatrix Corp PULM|Pheton Holdings (PTHL) - Ratio of Short-Term Indebtedness to Capital|Aptorum Group Ltd - Short-Term Debt to Capital|Short-Term Indebtedness to Equity LYRA|Impact BioMedical (IBO) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital TNFA (tnfpharma.com)|YCBD: Short-Term Debt to Equity|PRFX - Current Liabilities to Capital|Auris Medical - Short-Term Debt to Equity Ratio|LIPO: Short-Term Debt to Capital|Short-Term Debt to Equity OptiNose (OPTN)|Current Liabilities to Equity Pieris Pharmaceuticals Inc|PTPI - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital QLI|SLRN (Acelyrin, Inc.) - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient tffpharma.com TFFP